| Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis D Hanniford, A Ulloa-Morales, A Karz, MG Berzoti-Coelho, RS Moubarak, ... Cancer cell 37 (1), 55-70. e15, 2020 | 227 | 2020 |
| RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu, M Khan, PS Taunk, ... Cancer cell 34 (5), 757-774. e7, 2018 | 189 | 2018 |
| Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy X Cui, C Ma, V Vasudevaraja, J Serrano, J Tong, Y Peng, M Delorenzo, ... Elife 9, e52253, 2020 | 100 | 2020 |
| Molecular and clinicopathologic features of gliomas harboring NTRK fusions M Torre, V Vasudevaraja, J Serrano, M DeLorenzo, S Malinowski, ... Acta Neuropathologica Communications 8, 1-14, 2020 | 97 | 2020 |
| DNA methylation-based classification of sinonasal undifferentiated carcinoma S Dogan, V Vasudevaraja, B Xu, J Serrano, RN Ptashkin, HJ Jung, ... Modern Pathology 32 (10), 1447-1459, 2019 | 96 | 2019 |
| Cell surface notch ligand dll3 is a therapeutic target in isocitrate dehydrogenase–mutant glioma M Spino, SC Kurz, L Chiriboga, J Serrano, B Zeck, N Sen, S Patel, G Shen, ... Clinical Cancer Research 25 (4), 1261-1271, 2019 | 56 | 2019 |
| γδ T cells promote steatohepatitis by orchestrating innate and adaptive immune programming A Torres‐Hernandez, W Wang, Y Nikiforov, K Tejada, L Torres, A Kalabin, ... Hepatology 71 (2), 477-494, 2020 | 48 | 2020 |
| Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples MA Black, G Shen, X Feng, WFG Beltran, Y Feng, V Vasudevaraja, ... Journal of immunological methods 489, 112909, 2021 | 45 | 2021 |
| Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers R Bledea, V Vasudevaraja, S Patel, J Stafford, J Serrano, G Esposito, ... Scientific reports 9 (1), 16830, 2019 | 36 | 2019 |
| Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features M Torre, DM Meredith, A Dubuc, DA Solomon, A Perry, V Vasudevaraja, ... Journal of Neuropathology & Experimental Neurology 78 (4), 305-314, 2019 | 35 | 2019 |
| IDH2 R172 mutations across poorly differentiated sinonasal tract malignancies: forty molecularly homogenous and histologically variable cases with favorable outcome S Glöss, P Jurmeister, A Thieme, S Schmid, WY Cai, RN Serrette, ... The American journal of surgical pathology 45 (9), 1190-1204, 2021 | 30 | 2021 |
| TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition S Chiang, V Vasudevaraja, J Serrano, CJR Stewart, E Oliva, ... Modern Pathology 35 (1), 117-127, 2022 | 20 | 2022 |
| Innate αβ T cells mediate antitumor immunity by orchestrating immunogenic macrophage programming M Hundeyin, E Kurz, A Mishra, JAK Rossi, SM Liudahl, KR Leis, ... Cancer discovery 9 (9), 1288-1305, 2019 | 20 | 2019 |
| RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu, M Khan, PS Taunk, ... Cancer Cell 38 (4), 585-590, 2020 | 19 | 2020 |
| YAP1-FAM118B fusion defines a rare subset of childhood and young adulthood meningiomas KM Schieffer, V Agarwal, S LaHaye, KE Miller, DC Koboldt, T Lichtenberg, ... The American Journal of Surgical Pathology 45 (3), 329-340, 2021 | 17 | 2021 |
| Aberrant DNA methylation predicts melanoma-specific survival in patients with acral melanoma D Pradhan, G Jour, D Milton, V Vasudevaraja, MT Tetzlaff, P Nagarajan, ... Cancers 11 (12), 2031, 2019 | 17 | 2019 |
| GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors TE Richardson, K Tang, V Vasudevaraja, J Serrano, CM William, ... Journal of Neuropathology & Experimental Neurology 78 (12), 1089-1099, 2019 | 17 | 2019 |
| IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer S Mounika Inavolu, J Renbarger, M Radovich, V Vasudevaraja, ... CPT: pharmacometrics & systems pharmacology 6 (3), 168-176, 2017 | 13 | 2017 |
| DNA methylation profiling identifies subgroups of lung adenocarcinoma with distinct immune cell composition, DNA methylation age, and clinical outcome K Guidry, V Vasudevaraja, K Labbe, H Mohamed, J Serrano, BW Guidry, ... Clinical Cancer Research 28 (17), 3824-3835, 2022 | 12 | 2022 |
| Exploring DNA methylation for prognosis and analyzing the tumor microenvironment in pleomorphic xanthoastrocytoma K Tang, D Kurland, V Vasudevaraja, J Serrano, M Delorenzo, ... Journal of Neuropathology & Experimental Neurology 79 (8), 880-890, 2020 | 11 | 2020 |
